NCT00125307View on ClinicalTrials.gov

Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

February 29, 2008

Conditions
Lupus NephritisLupus Erythematosus, Systemic
Interventions
DRUG

tacrolimus

Trial Locations (1)

Unknown

Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00125307 - Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis | Biotech Hunter | Biotech Hunter